$40,000,000$3,000,000/EBITDA

The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients. The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the ...

$40,000,000$3,000,000/EBITDA
$3,000,000
property

40 Year Old Pharmaceutical Manufacturing Business

EBITDA

$3,000,000

Gross

$25,000,000

Price

$40,000,000

Vadodara For Sale

Vadodara Businesses for Sale, Find the Best Established Vadodara Businesses for Sale, Vadodara Businesses for Sale Marketplace, Buy a Vadodara  Business in, Vadodara  Companies for Sale, Discover opportunities for entrepreneurs in the United States, Vadodara  Companies for sale. Browse the Best Vadodara Businesses for Sale Available to Buy Now, Vadodara  Business for Sale, Explore Vadodara  Business for Sale, Vadodara  Business for Sale, Vadodara  Business Opportunities.

The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.

The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.

They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.

The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.

Research

Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.

Studies

Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.

Biotechnology

The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.

Team

The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.

Market:  65% India / 35% Rest of the World / Europe

Products:  25 OEM Products / Pharma Active Ingredients Raw Material

Most Sold:  Antibiotics

Standards:  ISO9001, EU Standards (No FDA)

Growth Rate:  20%+ / Year

Size:  100+ Employees

Management:  Chemical Engineer Background

Financial:  $25M Revenue / $3M EBITDA

Customers:

MergersCorp M&A
International As Seen On

  • brand 1
  • brand 1
  • brand 1
  • brand 1
  • brand 1